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1. Summary
Voltage-gated sodium (Nav) channels are intrinsic plasmamembrane proteins that
initiate the action potential in electrically excitable cells. They are a major focus of
research in neurobiology, structural biology, membrane biology and pharma-
cology. Mutations in Nav channels are implicated in a wide variety of inherited
pathologies, including cardiac conduction diseases, myotonic conditions, epilepsy
and chronic pain syndromes. Drugs active against Nav channels are used as local
anaesthetics, anti-arrhythmics, analgesics and anti-convulsants. The Nav channels
are composed of a pore-forming a subunit and associated b subunits. The b sub-
units are members of the immunoglobulin (Ig) domain family of cell-adhesion
molecules. They modulate multiple aspects of Nav channel behaviour and play
critical roles in controlling neuronal excitability. The recently published atomic res-
olution structures of the human b3 and b4 subunit Ig domains open a new chapter
in the study of these molecules. In particular, the discovery that b3 subunits
form trimers suggests that Nav channel oligomerization may contribute to the
functional properties of some b subunits.2. Introduction
Electrically excitable cells such as neurons and myocytes communicate via action
potentials, and voltage-gated sodium (Nav) channels play an essential role in this
process (figure 1). The vertebrate Nav channel a subunit is a single polypeptide
chain (molecular mass approx. 260 kDa) that contains the ion-selective com-
ponent. There are 10 mammalian a subunit genes encoding the proteins
Nav1.1–Nav1.9, and an atypical channel, Nax. Separate a subunit isoforms are
expressed in tissue-specific patterns and exhibit differences in gating behaviour
that tailor them for distinct physiological roles [1]. Each vertebrate Nav a subunit
contains four homologous but non-identical domains (I–IV), each of which con-
tains six transmembrane helical segments (S1–S6) (figure 2a). The domains
assemble around the central ion-selective pore [2]. Evidence based on m cono-
toxin GIIIA binding suggests that the domains may be organized in a
clockwise orientation as viewed from above the extracellular surface [3].
Currently, there are no high-resolution atomic structures of the complete ver-
tebrate Nav channel a subunit. However, the crystal structures of bacterial Nav
channels in different conformational states [4–6] (figure 2b) and a chimeric vol-
tage-gated potassium (Kv) channel [7] have been solved. They have provided
rich insights into the molecular basis of channel gating. All of the channels with
solved structures are homotetramers rather than a single molecule, so they lack
the sequence specializations found in the vertebrate Nav channel a subunit,
such as the distinct extracellular regions, the intracellular linkers between domains
and the unique carboxy-terminus (figure 2a). Nevertheless, the basic domain
organization of the vertebrate Nav channel is likely to be similar to the subunit
organization of the bacterial Nav channels and the Kv channel [8]. Using these
high-resolution structures as guides, we can say that helices S5 and S6 and the
60
40
20
–20
–40
–60
–80
–100
–120
0m
em
br
an
e 
po
te
nt
ia
l (
mV
)
de
po
la
riz
in
g 
di
re
ct
io
n
hy
pe
rp
ol
ar
iz
in
g 
di
re
ct
io
n
time (ms)
5 10 15
threshold
depolarizing
signal
inactivation gate
Nav channel Kv channel
Na+
K+
(b)
(a)
(c)
(d )
(b)
(a)
(c)
(d )
Figure 1. A simplified cartoon showing the main events underlying the action potential. (a) Neurons and other electrically excitable cells maintain a plasma
membrane resting potential of about 270 mV (the membrane potential is defined relative to the extracellular medium; a potential of 270 mV implies that
the cell interior is negative relative to the exterior). The negative resting membrane potential is largely set by the greater membrane permeability of potassium
ions compared with that of sodium ions. This occurs in the presence of a high intracellular potassium ion concentration relative to the extracellular media, and a high
extracellular to intracellular sodium ion concentration generated by sodium potassium ATPase activity. Under resting conditions, both voltage-gated sodium (Nav) and
voltage-gated potassium (Kv) channels are closed. The Nav channels begin to open in response to local membrane depolarization (generated for example by the
action of an ionotrophic neurotransmitter on its receptor). (b) The net inward flow of sodium ions causes further depolarization that opens more Nav channels, which
in turn causes even greater sodium ion entry and further depolarization. This positive feedback ensures the action potential generates a rapid ‘all or nothing’
response, whenever the initial stimulus is above a threshold value (here set at 250 mV). (c) In the ‘fast inactivation pathway’, sodium channels enter an inactive
state after a few milliseconds, whereby they cannot respond to any further membrane depolarization signals. Fast inactivation is driven by a conformational change
in which a hydrophobic sequence (the ‘inactivation gate’) lying within the cytoplasmic loop between domains III and IV moves to block the inner mouth of the pore
(see text). As a result, the action potential can only be propagated in the forward direction. The subsequent opening of voltage-gated potassium (Kv) channels
allows potassium ions to move out of the cell, down their electrochemical gradient. (d ) This moves the membrane potential in the hyperpolarizing direction, restores
the membrane to its resting potential and enables the Nav channels to recover from inactivation by returning to their closed conformation.
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2pore loop regions that connect them form the ion-selective pore
module. Helices S1–S4 of each domain comprise the voltage
sensor and lie on the outer rim of the pore module, at each
corner of the a subunit (figure 2b). Helix S4 of each voltage
sensor is amphipathic, with one face positively charged
(figure 2a,b). In response to the electric field changes produced
by membrane depolarization, helix S4 moves towards the
extracellular face of the membrane, thereby initiating confor-
mational changes that open the pore [4,7]. The voltage sensors
of domains I–III show the fastest kinetics and allow ion flow
to begin [9]. The domain IV voltage sensor responds more
slowly. Its movement frees an intracellular linker called the
inactivation gate that connects helix S6 of domain III with
helix S1 of domain IV (figure 2a) [10,11]. As a result, the inacti-
vation gate can now move to occlude the pore and drive the
channel into an inactivated state (figure 1). Thus, Nav channel
activation and inactivation are structurally, mechanistically
and functionally linked [8,12].
Most Nav channels isolated from vertebrate cells contain
associated b subunits. There are four b subunit genes
(Scn1b–Scn4b) encoding proteins b1–b4, respectively
[13,14]. Alternative splicing of the Scn1b gene adds furtherdiversity to the b1 protein [15]. As with the a subunits, indi-
vidual b subunits are expressed with distinct tissue
specificities [16]. All b subunits are type 1 intrinsic membrane
proteins. The extracellular amino-terminal region contains a
single V-type immunoglobulin (Ig) domain and a short
‘neck’. This is connected to a single a-helical transmembrane
domain and a carboxy-terminal intracellular region (figure
2a). However, the primary sequences of the b1 and b3 sub-
units are more closely related to each other than either is to
b2 or b4 [17]. The b1 and b3 subunits are non-covalently
bound to the a subunit, but the b2 and b4 subunits are cova-
lently attached to the a subunit via an inter-subunit disulfide
bond [18,19].
The b subunits can increase peak current density by
increasing the amount of channels in the plasma membrane
[13]. They also shift the voltage range over which activation
and inactivation occur, and they enhance the rates of inacti-
vation and recovery from inactivation [20,21]. They
therefore influence many of the key conformational changes
that Nav channels undergo during the action potential cycle
[13,16]. Although their gating effects can be subtle, they are
clearly important. Mice lacking individual b subunits show
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Figure 2. The subunit organization of the voltage-gated Nav channel. (a) Cartoon topology of the a and b subunits. Within the a subunit, domains I– IV, the
amphipathic helix S4 of the voltage sensors, the extracellular region between helices S5 and S6, the fast inactivation gate and the carboxy-terminus are shown.
(b) Top view from the extracellular face and side view of the Nav channel from the bacterium Arcobacter butzeri (PDB ID code 3RVY). Using this structure as a guide,
the inferred position of each vertebrate a subunit domain (I– IV) is shown colour-coded to match figure 2a. The location of the voltage sensors with the S4 helix for
domains III and IV, and the likely position of the S5–S6 extracellular regions of domains I and IV, are indicated.
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3a range of isoform-specific pathologies such as epilepsy,
ataxia and cardiac conduction diseases. Mutations in the b
subunits are associated with a number of human inherited
diseases, including epilepsy, neuropathies, cardiac conduction
diseases and some types of cancer [13,22].
Site-directed mutagenesis has been used to study the
function of b subunits. But these experiments were inter-
preted using structures inferred from homology modelling
[23–25], which is inevitably indirect. However, the structures
of the human b3 and b4 subunit Ig domains have recently
been solved at atomic resolution by X-ray crystallography
[26,27], and should now allow for much clearer functional
insights. In this review, we will focus on the new structural
determinations, and consider their pathophysiological impli-
cations. For a more in-depth discussion of additional aspects
of b subunit biology, especially the roles of these molecules in
development, signal transduction and their potential aspharmacological targets, we recommend other recent reviews
[13,16,22,28].3. The structure of the Nav channel b3
subunit Ig domain and implications for
the b1 structure
The X-ray structure of the human b3 Ig domain has been
solved to a resolution of 2.5 A˚. Surprisingly, it forms a
trimer in the asymmetric unit (figure 3a). This is not a crystal
packing artefact: super-resolution imaging detected trimeric
full-length b3 subunits as a major species in the plasma mem-
brane of HEK293 cells [27]. Moreover, atomic force microscopy
(AFM) imaged full-length b3 subunit monomers, dimers and
trimers isolated from transfected cells. The trimer is consistent
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Figure 3. The atomic resolution structure of the b3 subunit Ig domain (PDB ID code 4L1D). (a) Diagram showing the arrangement of the b3 trimer. Amino (N) and
carboxyl (C) termini are labelled. The Cys21–96 disulfide bond and the Cys2–24 disulfide bonds are labelled on the orange protomer. Potential N-linked gly-
cosylation sites Asn71, Asn85, Asn89 and Asn97 are shown as sticks and labelled for the orange protomer. Loops that are not resolved in the electron density
maps due to local disorder are shown in grey at their most probable plausible positions. (b) Close-up of the single Nav b3 subunit Ig domain protomer. Residues
correspond to loops not visible in the electron density maps due to local disorder are shown in grey. A close-up of the region surrounding the trimer interface is
shown in the box. (c) Cartoon of the full-length b3 trimer as it may appear on the plasma membrane, with correct dimensions. Note: in these diagrams, the amino
acids are numbered from the first residue of the mature protein (i.e. lacking the endoplasmic reticulum targeting signal) [27].
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4with previous evidence showing that when expressed in cells,
the full-length b3 subunits self-associate in cis, and that the Ig
domain is necessary for this interaction [25].
The Ig domain is one of the most common protein mod-
ules encoded by metazoan genomes, and is found in many
immune system proteins and cell-adhesion molecules
(CAMs) [29]. It is composed of a two-sheet sandwich of anti-
parallel b strands which adopt a Greek key topology encasing
a disulfide bond-stabilized hydrophobic core. The number
and location of the b strands can vary between Ig domains.
Loop regions between the b strands often exhibit local dis-
order when examined in the context of the protein crystal,
indicating inherent flexibility [30]. All of these structural fea-
tures are present in the b3 Ig domain, including a buried
disulfide bond Cys21–96 connecting the two faces. However,
to promote trimerization, the b3 Ig domain also has a moreunusual region of secondary structure. In most Ig domains,
the amino-terminal amino acids are held in place by an anti-
parallel b strand [30]. This feature is absent in b3. Instead, the
region is stabilized by a surface disulfide bond (Cys2–24) and
a salt bridge between residues Glu4 and Arg115. Conse-
quently, the hydrophobic amino acids Val3, Val5 and Pro6
are forced into a surface-exposed conformation that forms
the core of the trimer interface (figure 3b). Replacing residue
Cys24 with alanine in a C24A mutant prevents the formation
of the Cys2–24 disulfide bond and reduces trimer stability,
presumably because it interferes with the correct alignment
of the trimer interface [27].
The a-helical transmembrane domain of the b3 subunit
contains a conserved glutamic acid residue [23]. Peptides
encoding transmembrane a-helices with a membrane-
embedded glutamic acid readily form dimers and trimers,
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Figure 4. Structural features of the b3 trimer. (a,b) Evolutionary trace analysis [25] showing residues in red that are identical between b3 and b1 in all species for
which sequences are available, and mapped onto the b3 trimer in (a) top and (b) side view. The location of putative N-linked glycosylation sites Asn85 and Asn89,
and the cardiopathology mutation V86 within a distinct patch of conserved residues (as mentioned in the text), are indicated for the orange protomer. Disordered
loops are shown as grey ribbon. (c–e) Electrostatic surface potential (ESP) of b3 trimers in (c) top, (d ) side and (e) bottom view. ESP was calculated for the
trimer surface using the Adaptive Poisson-Boltzmann Solver (APBS) plug-in tool in PYMOL [33]. ( f ) The side face of the trimer showing the location of
N-linked glycosylation sites (cyan) and the location of separate cardiopathology mutations (purple) mentioned in the text.
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5stabilized by hydrogen bonds between the protonated glutamic
acid side chains [31]. We have therefore suggested that the
transmembrane glutamic acid residue acts to further stabilize
a full-length b3 trimer [27]. A cartoon of the proposed structure
for the full-length b3 trimer is shown in figure 3c.
Residues between b3 and b1 that are identical in all
species can be identified using evolutionary trace analysis[32]. In figure 4a,b, these amino acids are mapped onto the tri-
meric b3 Ig domain structure. Most of the trimer interface,
including the Cys2 and Cys24 residues, is fully conserved
between b3 and b1 [25], as are the surrounding amino
acids that help to align and stabilize the trimer interface.
This includes an unusual inward-pointing arginine residue
(Arg100), whose mutation in b1 is associated with febrile
rsob.royalsocietypublishing.org
6epilepsy [27,34,35]. The b3 Ig domain can interact with b1
when the two are co-expressed in the same cell [25],
suggesting that the trimer interface is functionally conserved
between b3 and b1. Furthermore, the a-helical transmem-
brane domain of b1 includes the unusual membrane-buried
glutamic acid residue noted above, and it occurs in the
same location on the transmembrane domain as with b3
[23,27]. Hence, many of the key features implicated in
b3 trimer stability are present in b1. All these factors taken
together suggest that the b1 subunit may also assemble into
a trimer in a manner broadly similar to b3.Open
Biol.5:1401924. Insights into Nav channel assembly and
a subunit gating from the b3 Ig
domain structure
A trimeric b3 structure implies that it may promote the oligo-
merization of up to three a subunits. Consistent with this,
AFM imaging detected heterogeneous complexes containing
the cardiac-specific a subunit Nav 1.5 cross-linked by b3
dimers and trimers. The frequency of these a subunit oligo-
mers was reduced to the background level when the Nav 1.5
a subunit was co-expressed with the trimer-disrupting C24A
b3 subunit mutant described above [27]. The C24A b3
mutant also attenuated the normal b3-induced gating shift in
the voltage sensitivity of inactivation for Nav 1.5 a subunits
[20]. Hence the oligomeric status of Nav 1.5 controlled by b3
can affect the electrophysiological properties of the channel.
The b3 subunit is expressed in the heart [36], and it plays
an important role in cardiac physiology, because the major
pathology associated with the Scn3b2/2 mouse is spon-
taneous cardiac arrhythmia [37,38]. The Scn1b2/2mouse also
displays cardiac conduction abnormalities [39]. Evidence that
the b1 subunit, like its homologue b3, can cross-link Nav 1.5
a subunits is provided by an interesting study by Mercier
et al. [40]. Here an Nav 1.5 a subunit mutant associated with
the cardiac conduction disease Brugada syndrome (BrS) was
retained in the endoplasmic reticulum of cardiomyocytes,
leading to reduced peak current. The mutation was also associ-
ated with reduced surface expression of the wild-type a
subunit, but only if mutant and wild-type a subunits were
co-expressed together with b1. Other 1.5 a subunit mutations
linked to BrS show similar dominant negative behaviour when
co-expressed with the wild-type a subunit in cardiomyocytes
[41–44]. Dominant negative phenotypes can often be
explained in molecular terms when mutant and wild-type sub-
units are jointly assembled into a multi-subunit complex, but
then every complex that contains any mutant subunit is func-
tionally inhibited. As a result, heterozygous individuals
expressing one mutant and one wild-type copy of a protein
display a much greater than 50% reduction of the functional
protein activity [45]. We suggest that, in vivo, individual Nav
1.5 a subunits do not behave as independent molecules, but
as oligomeric complexes in which multiple a subunits
co-assemble, and which the b3 and b1 subunits may help
stabilize. This may help explain why inherited Nav channel
cardiopathologies often behave as autosomal dominant
phenotypes in pedigree analysis studies [46].
In many—although by no means all—cell-expression sys-
tems, the b3 and b1 subunits shift the half maximal voltage
V1/2 for channel activation and inactivation by up to 15 mVin the hyperpolarizing direction (i.e. the voltages correspond-
ing to activation or inactivation of half the channels are
displaced to more negative values compared to correspond-
ing values shown by the a subunit alone; the action
potential threshold therefore assumes a more negative vol-
tage, leading to an increased likelihood of firing; figure 1).
With a subunit partners such as Nav 1.2, 1.3 and 1.5, Ig
domains of b3 and b1 are largely responsible for these
gating shifts [20,21,23,24,47]. To understand how they
might influence gating, we need to consider the structure
and location of the b subunit binding site(s) on the a sub-
units. Unfortunately, the detailed answer to this question is
uncertain; even the a : b stoichiometry is not clear. Although
the conventional view assumes that individual b subunits
bind a subunits at a single site [16], there is no over-riding
reason to think that this is correct in all cases. In fact, AFM
images show that b3 can bind to Nav 1.5 a subunits at up
to four locations around the a subunit [27], probably corre-
sponding to sites on each of the four a subunit domains.
On the other hand, the pseudo-symmetry of the vertebrate
a subunit domains means that there is no requirement for
eachbinding site tobe thermodynamicallyor structurallyequiv-
alent. These experiments were also conducted with a high level
of b3 expression, and without the presence of other b subunits,
so not all of the potential sitesmay be occupied byb3 inneurons
or myocytes. Nevertheless, they establish the fact that at least
under some conditions, a given type of b subunit can bind to
the a subunit at multiple locations.
There is currently no molecular information concerning
the b3 Ig domain binding site(s) on the a subunit. However,
given the structural similarity between the b1 and b3 subunit
Ig domains (figure 4a,b), it is at least plausible that these two
closely related b subunits may bind similar or overlapping
sites. The intracellular regions of both b1 and b3 do indeed
bind to similar sites on the Nav 1.5 a subunit carboxy-
terminus [48]. This would indicate that both b1 and b3 can
interact with the a subunit close to domain IV (figure 2a).
Interestingly, the local anaesthetic lignocaine binds to the S6
helix of domain IV [49], and both b3 and b1 attenuate ligno-
caine binding to Nav 1.3 [50]. A binding site for the b1 Ig
domain has been localized to the domain IV extracellular
S5–S6 region of the brain-type a subunit Nav 1.2 [51]. In a
separate study, two b1-binding sites on the muscle Nav 1.4
a subunit were mapped to the extracellular regions connect-
ing the S5–S6 helices of domain I and domain IV (figure 2a)
[52]. If the bacterial Nav channel structures accurately reflect
the topology of the vertebrate Nav channel, then these two b1
binding sites probably lie about 30–40 A˚ from each other
(figure 2b). Since the three-dimensional structure of these a
subunit extracellular regions is currently unknown, it is not
yet possible to say whether they extend far enough to form
a joint binding site. Assuming a top-view clockwise arrange-
ment of the a subunit domains [3], the S5–S6 extracellular
region of domain I lies closest to the voltage sensor of
domain IV, while the S5–S6 extracellular region of domain
IV abuts the voltage sensor of domain III. If b1 is like b3 and
forms a trimer, then viewed from above, its shape will be an
approximate equilateral triangle of side length about 60 A˚
(figure 3c). Based on the dimensions of the bacterial channel,
adjacent voltage sensors will be about 60–70 A˚ apart. Hence,
the Ig domains of b1 (and b3) at this site could lie close to the
a subunit voltage sensors of both domains IV and III. How
then could they influence voltage gating sensitivity?
rsob.royalsocietypublishing.org
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7A hyperpolarizing shift could occur if a negatively
charged protein is brought sufficiently close to a voltage
sensor so that it generates screening surface charge [53–56].
The calculated isoelectric points of the b1 and the b3 Ig
domains are 4.95 and 5.28, respectively, so they will both
carry a net negative charge at pH 7.4. Interestingly, the
electrostatic surface potential of the b3 trimer suggests a
dipole-like quality. Positive charges are concentrated on the
top surface and the clefts between protomers, although the
loop regions at each trimer vertex are negatively charged
(figure 4c,d ). By contrast, the trimer underside presents nega-
tive charges concentrated within a centrally located, shallow
concave face (figure 4e). The full significance of this curious
feature will remain unclear until the atomic resolution
structure(s) of the b3-binding sites on the a subunit are deter-
mined. But it is consistent with a role in presenting negative
charge to the a subunit voltage sensors.
An important consideration is that, in vivo, the b subunit Ig
domains are heterogeneously glycosylated [25,57]. Asparagine
(N)-linked glycosylation sites are defined by a conserved
Asn-X-(Ser/Thr) motif, in which X can be any amino acid
except proline [58] and mature N-linked sugar residues often
contain sialic acid moieties on their terminal branches [59].
When tested in CHO cells with Nav 1.2, 1.5 and 1.7, the
hyperpolarizing gating shifts induced by b1 were abolished,
both by mutagenic removal of the N-linked sites and by
using a cell-line lacking sialyl transferase [60]. This indicates
an important role for sialylation of the b1 Ig domain
N-linked glycosylation sites in modulating the gating vol-
tage shifts. The same post-translational modifications will
undoubtedly occur on the b3 Ig domain. There are four poten-
tial N-linked glycosylation sites per b3 Ig domain protomer,
and all of them point outwards from the surface-exposed
faces of the trimer [27] (figure 4f ). The potential N-linked
glycosylation sites Asn85 and Asn89 are particularly interest-
ing. They are fully conserved between b3 and b1 in all
known species (figure 4b), as are the immediately surrounding
residues Val86, Thre87 and Gly92 [25,27]. Furthermore, these
two N-linked glycosylation sites lie close to two amino acids
that are separately mutated in different inherited cardiopathol-
ogies: V86I [61] and V12M [62] (figure 4f ). Residue V12
normally forms a hydrophobic contact with Leu116 of an
adjacent protomer that helps maintain the correct trimer
organization [27]. The V12M mutation probably destabilizes
this interaction. Two further mutations in the b3 Ig domain
that are associated with inherited cardiopathologies have
been described. These are A106V [63] and V30G [64], and
occur on adjacent Ig domain loops (figure 4f ). In the crystal
structure, the conformation of these two regions is unresolved
due to local disorder (figure 3a,b) [27]. In other Ig domains, the
equivalent loop regions can act as binding sites for interacting
proteins. For example, these regions of antibody Fab fragment
Ig domains constitute the antigen-binding site [30]. In b3, their
flexible nature, outwardly pointing locations and associations
with cardiopathologies make them plausible candidates for an
a subunit binding site—perhaps interacting with the S5–S6
extracellular regions of domains I and IV (and see also §5).
We suggest that the hyperpolarizing shifts in voltage
gating shown by the b3 and b1 subunits are caused by an
electrostatic mechanism in which the Ig domain is held in
place via binding to extracellular regions of the a subunit.
This would position the Ig domains so as to present negative
charges from sialic acid residues (and perhaps the proteinsthemselves), close enough to one or more voltage sensors to
affect gating behaviour, as previously proposed [55,56,60]. It
should be noted, however, that in some other expression sys-
tems the same b subunits can produce depolarizing shifts in
the V1/2 values for activation and inactivation [65–67]. Fur-
thermore, the magnitude of the shifts can vary between a
subunit partners. For example, it has been reported that b3
subunits have little or no effects on the gating voltage sensi-
tivity of Nav 1.8 and Nav 1.6 [22,68]. It is hard to see how
such differences can arise, other than by variations in post-
translational modification and/or cell-specific and isoform-
specific differences in the precise molecular organization of
the subunits within the channel complex. An additional
factor may be the wider molecular environment of the channel.
The Nav channels do not exist in isolation on the plasma mem-
brane, but as part of local protein clusters that include other
ion channels and CAMs [69]. The influence of this clustering
on b subunit-induced gating shifts remains to be characterized.
The b3 and b1 subunits can also enhance the rate of inacti-
vation and recovery from inactivation, and increase the
fraction of channels that gate in a fast-acting mode [23,70,71].
Within the a subunit, the carboxy-terminal domain binds to
the inactivation gate, and this interaction stabilizes fast inacti-
vation [72]. The a subunit carboxy-terminal domain also
binds to the intracellular region of b3 and b1. An epilepsy-
associated mutation in the carboxy-terminal domain of Nav
1.1 disrupts this interaction and attenuates the normal b1-
induced enhancement of inactivation [48]. This suggests that
these b subunits may facilitate fast inactivation by binding to,
and optimally aligning the complex between, the a subunit
carboxy-terminal domain and the inactivation gate. NMR
studies on the intracellular regionb3 intracellular region indicate
that it is largely disordered, but with a short juxtamembrane
sequence that can adopt a negatively charged amphipathic
a-helix [65] (figure 3c). The intracellular regions are long
enough to form a complex with the a subunit carboxy-terminus
and the inactivation gate. But the formation of a subunit oligo-
mers viab3- andb1-induced cross-linking could greatly facilitate
and stabilize these interactions. TheNav channel oligomerwould
then behave as an integrated allosteric protein [73]. Consistent
with this proposal, it has been shown that mutational disruption
of the b1 region equivalent to the b3 trimer interface reduced the
fraction of Nav 1.2 that acted in the fast-gating mode [74].5. The b4 Ig domain structure and
functional implications
The structure of the human b4 Ig domain has been solved at
1.7 A˚ resolution [26]. Overall, the Ig domains of b4 and a b3
protomer are remarkably similar, despite their low level of
sequence similarity (figure 5a,b). However, there are also
some striking differences. The most obvious is that the b4
Ig domain is a monomer in the crystal asymmetric unit.
There is currently no evidence that b4 forms cis homodimers
or homotrimers in vivo. Unusually for an Ig domain, the first
seven amino-terminal residues (which in b3 comprise the
trimer interface) are disordered and unresolved in the b4
Ig domain crystal structure. There are also significant
sequence differences in this region between b4 and b3. In
particular, the C2–24 disulfide bond is not present in b4,
because the equivalent cysteine residue at position 2 is not
present. The Cys24-equivalent residue is present in b4 as
Ala58
Val30 Val30 (b3)
Ala58 (b4)
NH2
NH2
NH2
NH2
(b)(a)
Cys53–131
Cys21–96
Cys2–24
COOH
(to transmembrane domain)
COOH
(to transmembrane domain)
COOH
(to transmembrane domain)
A
D
C
D
C
1
10
27
8
3
9
6
5 4
H
BE F
G
b4 Ig domain b3 Ig domain
Figure 5. The atomic resolution structure of the b4 subunit Ig domain. (a) The b4 Ig domain (PDB ID code 4MZ2) and comparison with similar orientation with
the b3 Ig domain. (b) Supposition of the b4 Ig domain (cyan) and a single b3 Ig domain protomer (orange), showing the location of the Ala58 residue (corre-
sponding to the free Cys58 residue of b4) and the Val30 residue of b3 mentioned in the text.
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8Cys58, but to avoid potential complications caused by the
presence of a free cysteine, this residue was mutated to ala-
nine in the protein used for crystallization. The Cys58
residue forms a disulfide bond with the a subunit in vivo
[18], and so must be located within an a subunit binding
site of the b4 subunit. Residue 58 is surrounded by side
chains of bulky hydrophobic amino acids—particularly
Phe59, which is exposed and outward-pointing in the crystal
[26], but which is probably buried into a suitable hydro-
phobic pocket on the a subunit when correctly assembled
in vivo. Interestingly, residue 58 is located on one of the b4
Ig domain surface loops, although the region appears notably
less flexible than the corresponding loop in the b3 protomer
(figure 5a) [26]. When the b4 and b3 structures are overlaid
(figure 5b), the region of b4 surrounding residue 58 directly
corresponds to the loop region of b3 that contains the V30G
cardiopathology mutation noted above (figure 4f ). This pro-
vides some additional evidence that the loop regions of the b
subunit Ig domains may be a subunit binding sites (see §4).
In common with most Ig domains, the b4 structure con-
tains a buried disulfide bond (C53–131) (figure 5a) [30].
The conventional view has been that the disulfide bond
stabilizes Ig domain folding by covalently connecting the
two b sheet faces. Surprisingly, however, a C131W mutation
still folded and was efficiently exported to the plasma
membrane through the secretory pathway. Rather than com-
pletely disrupting folding, X-ray crystallographic analysis
revealed that the C131W mutation had a more subtle and
interesting effect. Breaking the internal disulfide bond led
to a local remodelling of the b sheets surrounding the
Cys58-containing loop region [26]. This work has important
implications for other b subunits. In particular, an equivalent
mutation (C121W) in b1 causes generalized epilepsy with
febrile seizures plus (GEFSþ). Here, the mutant b1 subunit
can no longer bind to and modulate the brain-specific Nav
1.2 a subunit [75]. It is therefore probable that in b1, the
C121Wmutation selectively perturbs an a subunit interaction
site on the b1 Ig domain loop region.The b4 binding site(s) on the a subunit are unclear.
However, one clue comes from the ability of b4 to inhibit
toxin-binding. For example, co-expression of b4 with the
Nav 1.2 a subunit reduced the affinity of the tarantula toxin
ProTx-II for the channel, and b4 also reduced sodium
influx in Nav 1.2 when tested with the scorpion toxin TsVII
[26]. The ProTx-II toxin binds to the a subunit voltage sensors
of domains I, II and IV, and TsVII binds predominantly to the
a subunit voltage sensor of domain II [10]. On this basis, it
has been suggested that b4 may influence the domain II vol-
tage sensor [26]. This presumed b4 binding site on the a
subunit is different from the one known b1 binding site
noted above, and Nav 1.1 channels can be isolated containing
both non-covalently associated b1 and covalently bound b4
subunits [76]. On the other hand, under conditions of high
expression, b4 can partially (but not completely) displace
b1 from Nav 1.1 [76]. Hence, a more subtle possibility is
that the b4 and b1 subunits may bind at more than one site
on this a subunit, some of which are overlapping. This is
reminiscent of the multiple b3 binding sites on Nav 1.5
detected by AFM and noted earlier. If so, then there are
some interesting implications. In neurons, expression of the
a and b subunit isoforms can change significantly, both
during development [77] and in some pathologies such as
diabetic neuropathy [78] and neuropathic pain [79]. If b3
and b1 can induce a subunit cross-linking, while monomeric
b4 cannot, then varying expression of different structural
classes of b subunits may differentially modulate the oligo-
meric state of the channels, and this will contribute to both
structural and functional heterogeneity within the Nav
channels on the plasma membrane.
A unique aspect of b4 behaviour is its ability to promote
‘resurgent current’. This phenomenon occurs when channels
are opened by membrane depolarization but are rapidly
blocked by an endogenous protein that inhibits current flow,
yet also prevents binding of the fast inactivation gate to the
pore. Following membrane repolarization, the blocker is
removed, leading to a brief resurgent current flow before the
10 µm
(b)(a)
Figure 6. The rat neuronal-like cell-line PC12 expresses the b3 subunit endogenously [23]. (a) b3 accumulation at the contact site between two PC12 cells, as
detected by immunofluorescence microscopy, and (b) DIC image of the same cells. Cells were stained with an affinity-purified rabbit polyclonal antibody raised
against a b3-specific peptide corresponding to the intracellular region of the molecule. The antibody has been described previously. It detects b3 in both Western
blotting and immunohistochemistry experiments, and its binding is inhibited by prior incubation with the immunizing peptide [92]. The PC12 cells were fixed,
permeablized and stained as described previously [93].
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9channels inactivate via the conventional pathway [80]. The
blocking factor has been localized to sequences within the b4
intracellular region [81]. As with b3, the secondary structure
of the b4 intracellular region is predominantly disordered,
but with a short segment adjacent to the membrane that dis-
plays amphipathic a-helical potential—although in the case
of b4, the charges along one face of the helix are positive. It
is these charges that are critical for the resurgent current
effect [82]. Disordered regions of proteins can sample many
different conformations simultaneously, and can provide
high-specificity binding even with low intrinsic affinity [83].
They may be advantageous in situations encountered by the
intracellular regions of both b3 and b4, with their requirement
for different binding interactions occurring at specific parts in
the channel gating cycle.
The b4 subunit is closest in sequence identity to b2. The
b2 subunit also contains a free cysteine at the equivalent pos-
ition to Cys58, and likewise forms a disulfide bond with the a
subunit in vivo [19]. However, it is not known if b2 and b4
share overlapping binding sites. For Nav 1.5, the b2 subunit
induces hyperpolarizing gating shifts that are sialic-acid-
dependent [84]. On the other hand, the b2 subunit induces
sialic-acid-independent depolarizing gating shifts for Nav
1.2 [84]. There are currently no structural explanations for
these strikingly disparate effects. Again, they emphasize the
complex isoform-specific nature of the binding interactions
between Nav a and b subunits. Mice lacking b2 expression
have a relatively mild phenotype, although they are more
prone to seizures. Interestingly, these mice display a signifi-
cantly reduced Nav channel density in some classes of
neurons, especially in the hippocampus [85]. It is therefore
possible that b2 has a particularly important role in stabilizing
Nav channels in the plasma membrane [86].6. The Nav b subunits as cell-adhesion
molecules
The Nav b subunits are related to members of the CAMs
superfamily [17], and there is growing evidence that b sub-
units display CAM-like behaviour both in cis and in trans.
The b1 subunit Ig domain can interact in cis with other
CAMs such as neurofascin-155 and neurofascin-186, contac-
tins and cadherins, and b3 can bind neurofascin-186[87,88]. The b1 and b2 subunits interact with extracellular
matrix proteins such as tenascin-R that are secreted by oli-
godendrocytes during myelination [89]. These multiple
interactions all help localize Nav channels to discrete clus-
ters at the nodes of Ranvier in myelinated neurons, and
probably increase the total amount of Nav channels in the
membrane.
The Nav b subunits also act as trans-binding CAMs inde-
pendently of a subunits. This has been conveniently studied
by expressing them in the Drosophila S2 cell-line and monitor-
ing cell adhesion visually. Here, the b1 and b2 subunits
promoted cell adhesion [90], while the b3 subunit did not
[91]. On the other hand, b3-mediated cell adhesion was
detected when assayed in more physiologically mammalian
cell-lines, both by immunoprecipitation [25] and by immuno-
fluorescence (figure 6). The trans cell adhesion of b3-subunits
required an intact Cys2–24 disulfide bond [25]. Hence, the
cis-formed b3 trimer is probably needed to form the trans-
binding cell–cell contacts. This is similar to the behaviour
shown by the CAM myelin P0 which stabilizes the myelin
sheath around peripheral neurons [94]. The myelin P0 mol-
ecules assemble as tetramers in cis, and then the tetramers
associate in trans to form tight intercellular contacts [94]. It
may be significant that myelin P0 is a distant paralogue of
the Nav b subunits, and its Ig domain has previously been
used to model both the b1 and b3 Ig domains [23,25,74,95].
The demonstration that at least some b subunits have both
cis and trans CAM activity complicates the interpretation of
knockout mouse phenotypes. For example, rapid conduction
in the heart requires the cardiomyocytes to be electrically
coupled to each other via their apposed intercalated discs
[46,96]. The b subunits are located on the intercalated discs
of ventricular cardiomyocytes [38,97,98], and their absence
will probably have multiple effects: the Nav channels will
display altered gating behaviour and their location at the inter-
calated discs may be destabilized, but cell adhesion between
cardiomyocytes could also be compromised, potentially lead-
ing to loss of signal cohesion during the intercellular
propagation of the cardiac action potential. We should be
open to the possibility that some of the pathologies shown
by b subunit knockout mice (and by the human pathologies
associated with b subunit mutations) reflect abnormalities in
cell adhesion rather than direct electrophysiological effects
on the Nav channels themselves.
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107. Summary
An earlier review described Nav channel b subunits as ‘any-
thing but auxiliary’ [99]. We agree with this sentiment, and
we emphasize the integration of the b subunits with other
Nav channel components.As a case in point,we note the current
interest in the pharmacological potential of animal toxins that
target Nav channels [100]. In some examples, the binding affi-
nity of these toxins for Nav channels is actually increased by
the presence of specific b subunits [101,102]. This raises interest-
ing questions about the nature of the toxin-binding sites. The
important point is that these toxins evolved to act against Nav
channels in their normal physiological context, which includes
the b subunits.We suggest that screening assays for such toxinsand drugs should include, wherever possible, the relevant b
subunit(s) for the Nav channels in question.
These are interesting times for Nav channel b subunit
research. The new results from X-ray crystallography and
molecular imaging provide the first detailed look at the
molecules, and will encourage both the generation of detailed
functional hypotheses and their experimental testing.
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